FDA Approves Use of HPV Vaccine for People 27 to 45

Modesto Morganelli
Ottobre 11, 2018

The Food and Drug Administration stretched its approval for the HPV vaccine that includes both women and men between the age group 27 to 45, making an effort in protecting more people from various types of cancer those are caused by the above-mentioned virus.

The FDA based its decision to change guidance on three studies involving separate populations of women and men - namely one study of 3,200 women ages 27 to 45 that showed 88 percent efficacy against certain warts, lesions and cervical cancers.

"The Centers for Disease Control and Prevention has stated that HPV vaccination prior to becoming infected with the HPV types covered by the vaccine has the potential to prevent more than 90 percent of these cancers, or 31,200 cases every year, from ever developing", said Peter Marks, MD, PhD, director of the FDA's Center for Biologics Evaluation and Research.

The U.S. agency, which made the announcement Friday, had approved the use of Gardasil 9 for use in men and women 9 through 26 in 2014.

Rohr-Allegrini said even if you've already tested positive for a strain of HPV, the vaccine can protect you against other cancer-causing strains to which you may not yet have been exposed. Because HPV causes most cervical cancers, women can now not do the pap smear at all and just get HPV testing every 5 years as a new option.

View the original story on KCCI's website. It also relied on immunogenicity data from a clinical trial in which 150 men, 27 through 45 years of age, received a 3-dose regimen of Gardasil over 6 months. It no longer is distributed in the United States because a new version of the vaccine, Gardasil 9, covers the same four HPV types and an additional five types. The most commonly reported adverse reactions were injection site pain, swelling, redness and headaches.

Regarding prevention and treatment, Brown recommends the HPV vaccine, widely provided to everyone regardless of sex, gender, or sexual orientation before sexual debut, and for genital wart treatment.

The works I contrast to the human papillomavirus, HPV that can also bring along cancers of the vulva, and genital warts, penis, anus, and parts of the throat. "But, that said, it protects against nine types of HPV, so if you have one of the types, you still can be protected from other HPV types".

Most HPV infections, including potentially cancer-causing varieties, go away on their own, the National Cancer Institute says.

She and Dr. William Schaffner, an infectious disease expert at Vanderbilt University, said people over 26 began asking doctors about the vaccine.

According to the CDC, HPV infections are responsible for approximately 27,000 new cancer diagnoses each year in the United States. This has huge implications for men and women. The recommended dose for those over 26 will be three doses.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE